After debuting with 370$ million capital raise in September 2024, Candid Therapeutics, a San Diego-based biotechnology company specializing in T-cell …
Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotechnology company, has announced preclinical Proof-of-Concept (PoC) results for a precision cancer vaccine …
Relay Therapeutics, a clinical-stage precision medicine company, has announced updated interim clinical data for its investigational allosteric PI3Kα inhibitor, RLY-2608, …
Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has announced the nomination of its 21st pre-clinical candidate, ISM8969, an …
Xaira Therapeutics, an integrated biotechnology company focused on leveraging AI to transform drug discovery and development, announced two key appointments …
Relation Therapeutics announced two strategic collaborations with GSK aimed at advancing drug discovery for fibrotic diseases and osteoarthritis, debilitating conditions …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.